TNIK-IN-9 (Compound 54) is a selective and potent NIK inhibitor with an IC50 of 1.27 nM. It effectively suppresses the production of pro-inflammatory cytokines and nitric oxide. In sepsis models, TNIK-IN-9 demonstrates significant anti-inflammatory effects, reduces mortality, and provides liver protection.
Target-Kategorie:
NF-kappaB
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
